Alendronate reduces serum TNFα and IL-1β, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis

Author: Papadaki Helen A.   Tsatsanis Christos   Christoforidou Anna   Malliaraki Niki   Psyllaki Maria   Pontikoglou Charis   Miliaki Maria   Margioris Andrew N.   Eliopoulos George D.  

Publisher: Springer Publishing Company

ISSN: 0914-8779

Source: Journal of Bone and Mineral Metabolism, Vol.22, Iss.6, 2004-11, pp. : 577-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content